LRG1 Antikörper

Produktnummer ABIN2191876

Dieses Maus Monoklonal-Antikörper erkennt spezifisch LRG1 in WB und IA. Er zeigt eine Reaktivität gegenüber Human und wurde in 1 Publikation erwähnt.

Kurzübersicht für LRG1 Antikörper (ABIN2191876)

Target: LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser LRG1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunoassay (IA)

Klon: 2F5-A2

Produktdetails anti-LRG1 Antikörper

Sterilität: 0.2 μm filtered

Anwendungsinformationen

Applikationshinweise: and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Haltbarkeit: 12 months

Referenzen für anti-LRG1 Antikörper (ABIN2191876)

Codina, Vanasse, Kelekar, Vezys, Jemmerson: "Cytochrome c-induced lymphocyte death from the outside in: inhibition by serum leucine-rich alpha-2-glycoprotein-1." in: Apoptosis : an international journal on programmed cell death, Vol. 15, Issue 2, pp. 139-52, (2010) (PubMed).

Details zu LRG1

Target: LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))

Andere Bezeichnung: Leucine-Rich alpha-2-Glycoprotein

Hintergrund: The monoclonal antibody recognizes leucine-rich alpha-2-glycoprotein (LRG), a member of the leucine- rich repeat family. LRG is a plasma protein of approximately 50 kDa. LRG consists of 312 amino acids. It has 1 galactosamine and 4 glucosamine oliogosacharides attached and has 2 intrachain disulfide bonds. Leucine comprises 66 of the 312 amino acids, and LRG contains at least eight 24-amino acid leucine-rich repeats. The consensus of these residues, termed leucine-rich repeats (LRR), has been identified as an LRR-containing domain. The primary function of LRRs is to provide versatile structural framework of the formation of protein-protein interactions. LRG is expressed during granulocyte differentiation. Although several family members of the leucine-rich repeat family have been shown to be involved in signal transduction, protein-protein interaction, or cell adhesion and development, a function for LRG remains elusive. LRG has been reported as a biomarker for certain diseases including microbial infections and cancer. LRG can be detected in human neutrophils and progenitor cells, but not in peripheral blood mononuclear cells. The monoclonal antibody 2F5.A2 can be used for immuno purification of human LRG. Aliases Leucine-rich alpha-2-glycoprotein, LRG Immunogen Human LRG, covalently coupled to hemocyanin using glutaraldehyde

Pathways: Brown Fat Cell Differentiation